Nilsson, Stockholm
Andreas Nilsson, Stockholm SE
Bjorn M. Nilsson, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20110015185 | Benzofuran Compounds - The present invention relates to compounds of formula (I): | 01-20-2011 |
20110098310 | NOVEL COMPOUNDS, USE AND PREPARATION THEREOF - The present invention relates to compounds of the general formula (I) wherein R | 04-28-2011 |
Björn M. Nilsson, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20110015185 | Benzofuran Compounds - The present invention relates to compounds of formula (I): | 01-20-2011 |
Erik Nilsson, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20090045200 | BEVERAGE PACKAGE CONTAINER - Beverage package container includes an opening, which is resealable using a sealing device, where the package container is essentially or completely parallelepipedic, including a hollow, box-shaped body and the sealing device, where a corner of the parallelepipedic, hollow, box-shaped body is chamfered, at which corner a triangular surface is formed, connecting to the box-shaped body, where a tube-shaped part extends out from the surface, including the opening. The sealing device has an essentially pyramid-shaped body, designed so that it, together with the body, forms the parallelepipedic package container when it bears on the triangular surface of the box-shaped body, and a cavity for receiving the tube-shaped part, and where cooperating members are arranged, on the tube-shaped part as well as in the cavity, for removably and tight-fittingly detaining the sealing device at the tube-shaped part, so that the box-shaped body and the sealing device together form a parallelepiped. | 02-19-2009 |
Fredrik Nilsson, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20090016957 | Polypeptides - This invention relates to polypeptides which bind to EGFR family receptors and to applications of those polypeptides in medicine, veterinary medicine, diagnosis diagnostics and imaging. | 01-15-2009 |
20100048868 | Polypeptides Having Binding Affinity for Her2 - A polypeptide is provided, which has a binding affinity for HER2 and which is related to a domain of staphylococcal protein A (SPA) in that the sequence of the polypeptide corresponds to the sequence of the SPA domain having from 1 to about 20 substitution mutations. Nucleic acid encoding the polypeptide, as well as expression vector and host cell for expressing the nucleic acid, are also provided. Also provided is the use of such a polypeptide as a medicament, and as a targeting agent for directing substances conjugated thereto to cells overexpressing HER2. Methods, and kits for performing the methods, are also provided, which methods and kits rely on the binding of the polypeptide to HER2. | 02-25-2010 |
20100316602 | COMPOSITIONS AND METHODS FOR TREATMENT OF ANGIOGENESIS IN PATHOLOGICAL LESIONS - Treatment of lesions of pathological angiogenesis, especially tumors, rheumatoid arthritis, diabetic retinopathy, age-related muscular degeneration, and angiomas. A conjugate is used comprising a molecule that exerts a biocidal or cytotoxic effect on target cells in the lesions and an antibody directed against an extracellular matrix component which is present in such lesions. The antibody may be directed against fibronectin-2 (IL-2), doxorubicin, interleukin-12 (IL-12), Interferon-γ (IFN-γ), Tumor Necrosis Factor α (TNFα) or Tissue Factor protein (which may be truncated). | 12-16-2010 |
20130005653 | POLYPEPTIDES - This invention relates to polypeptides which bind to EGFR family receptors and to applications of those polypeptides in medicine, veterinary medicine, diagnosis diagnostics and imaging. | 01-03-2013 |
20140178301 | POLYPEPTIDES - This invention relates to polypeptides which bind to EGFR family receptors and to applications of those polypeptides in medicine, veterinary medicine, diagnosis, diagnostics, and imaging. | 06-26-2014 |
20140348784 | COMPOSITIONS AND METHODS FOR TREATMENT OF ANGIOGENESIS IN PATHOLOGICAL LESIONS - Treatment of lesions of pathological angiogenesis, especially tumors, rheumatoid arthritis, diabetic retinopathy, age-related muscular degeneration, and angiomas. A conjugate is used comprising a molecule that exerts a biocidal or cytotoxic effect on target cells in the lesions and an antibody directed against an extracellular matrix component which is present in such lesions. The antibody may be directed against fibronectin-2 (IL-2), doxorubicin, interleukin-12 (IL-12), Interferon-γ (IFN-γ), Tumor Necrosis Factor α (TNFα) or Tissue Factor protein (which may be truncated). | 11-27-2014 |
Jens Nilsson, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20140187327 | Information Updating Management in a Gaming System - Updating information in a client-server based gaming system comprising a client gaming machine, a game application server and a central database, by: storing in said central database login information for gaming system units that are logged in to the gaming system; storing updated information in the central database; storing an information update control command comprising an indication of the updated information and an indication of a receiver gaming system unit in the central database; generating an update command message comprising an update command for execution of an update operation in the receiver gaming system unit; determining the communication route to the receiver gaming system unit dependent on the stored login information; communicating the update command message to the receiver gaming system unit dependent on the determined communication route; executing the update command comprised in the update command message in the receiver gaming system unit. | 07-03-2014 |
Joakim Nilsson, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20140128056 | Methods and Devices for Setting ROT Limit - Methods and devices to dynamically determine suitable cell-specific RoT limits are provided. The suitable cell-specific RoT limits can advantageously be set both with respect to a short time scale and a long time scale In accordance with some embodiments the long term time scale operation is based on UE measurements representative for the intended coverage area of the cell. In accordance with some embodiments the short term time scale operation is based on UE measurements from active User Equipments only. Furthermore, also receiver capabilities of and cell isolation to neighboring base stations can be considered in the long time scale operation. | 05-08-2014 |
Magnus Nilsson, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20130144792 | STAND-ALONE SECURE PIN ENTRY DEVICE FOR ENABLING EMV CARD TRANSACTIONS WITH SEPARATE CARD READER - A method of conducting secure electronic payments to a payment acquirer using a credit card payment unit, comprising of a smart card, a portable card reader device, a mobile phone, a stand-alone PIN entry device and a payment server. The method is based on eliminating the unsecure keyboard in a mobile phone used for entering personal identification information, and instead use a separate secure PIN entry device which fulfils the EMV Level specification. Since all sensitive payment information, communicated to the payment server from the card reader and the PIN entry device, is encrypted using unique encryption keys an unsecure mobile phone may be used for relaying the communication between the card reader device and the PIN entry device to and from the payment server. | 06-06-2013 |
Malin Nilsson, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20100095893 | ROTARY PARLOUR FOR AUTOMATIC MILKING OF ANIMALS - A rotary parlour for automatic milking of animals includes an annular rotary platform ( | 04-22-2010 |
Marcus Nilsson, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20160007115 | WIRELESS SPEAKER ARRANGEMENT - The present invention relates to a wireless speaker arrangement. The present invention also relates to a wireless speaker system comprising at least a pair of such speaker arrangements, to a method for operating a wireless speaker arrangement and to a corresponding computer program product. | 01-07-2016 |
Marianne Nilsson, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20130102587 | New Enzyme Inhibitor Compounds - Disclosed are compounds which inhibit SSAO enzyme activity. Also disclosed are pharmaceutical compositions comprising these compounds and the use of these compounds in the treatment or prevention of medical conditions wherein inhibition of SSAO activity is beneficial, such as inflammatory diseases, immune disorders and the inhibition of tumour growth. | 04-25-2013 |
20140357623 | NEW ENZYME INHIBITOR COMPOUNDS - 2-{4-[1-(4-chlorophenyl)-1H-pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl}ethan-1-amine; 3-aminopropyl 4-[1-(4-chlorophenyl)-1H-pyrrolo[2,3-c]pyridin-3-yl]piperidine-1-carboxylate; 1-{4-[1-(4-chlorophenyl)-1H-pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl}-4-(dimethylamino)butan-1-one; 5-amino-1-{4-[1-(4-chlorophenyl)-1H-pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl}pentan-1-one; N-(2-aminoethyl)-4-[1-(4-chlorophenyl)-1H-pyrrolo[2,3-c]pyridin-3-yl]piperidine-1-carboxamide; N-(3-aminopropyl)-4-[1-(4-chlorophenyl)-1H-pyrrolo[2,3-c]pyridin-3-yl]piperidine-1-carboxamide; 4-[1-(4-chlorophenyl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-N-[3-(dimethylamino)propyl]piperidine-1-carboxamide; 1-({4-[1-(4-chlorophenyl)-1H-pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl}carbonyl)piperazine; 4-({4-[1-(4-chlorophenyl)-1H-pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl}carbonyl)morpholine; 1-({4-[1-(4-chlorophenyl)-1H-pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl}carbonyl)-1,4-diazepane; ethyl 1-[1-(4-chlorophenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]piperidine-4-carboxylate; ethyl 1-[1-(4-methylphenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]piperidine-4-carboxylate; 1-[1-(4-chlorophenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]piperidine-4-carboxylic acid; N-(2-aminoethyl)-1-[1-(4-chlorophenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]piperidine-4-carboxamide; 4-({1-[1-(4-chlorophenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]piperidin-4 yl}carbonyl)morpholine; 1-({1-[1-(4-chlorophenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]piperidin-4-yl}carbonyl)piperazine; {4-[1-(4-methylphenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]morpholin-3-yl}methanol; {4-[1-(4-methyl-phenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]morpholin-2-yl}methanol; [(3R)-4-[1-(4-chlorophenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]morpholin-3-yl]methanol; methyl 4-[1-(4-chlorophenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]morpholine-3-carboxylate; N-(2-aminoethyl)-4-[1-(4-chlorophenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]morpholine-3-carboxamide; 2-{4-[1-(4-chlorophenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]morpholin-3-yl}ethan-1-ol; methyl 1-[1-(4-chlorophenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]piperidine-2-carboxylate; N-(2-aminoethyl)-1-[1-(4-chlorophenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]piperidine-2-carboxamide; 1-({1-[1-(4-chlorophenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]piperidin-2-yl}carbonyl)piperazine; 4-[1-(4-methylphenyl)-1H-pyrrolo[2,3-c]pyridin-3-yl]morpholine; 1-(4-chlorophenyl)-3-(piperidin-4-yl)-1H-pyrrolo[2,3-c]pyridin-4-ol; N-butyl-1-(4-chlorophenyl)-N-methyl-1H-pyrazolo[3,4-c]pyridin-3-amine; 1-[4-(fluoromethyl)phenyl]-3-(oxan-4-yl)-1H-pyrazolo[3,4-c]pyridine; and 3-({4-[1-(4-chlorophenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]piperidin-1-yl}methyl)pyridine are useful for the inhibition of SSAO activity. | 12-04-2014 |
Roland Nilsson, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20160032401 | Glycine, Mitochondrial One-Carbon Metabolism, and Cancer - Methods of treatment, diagnosis, and determining prognosis of subjects with cancer, generally comprising determining levels of glycine metabolism or a mitochondrial 1-carbon (1-C) pathway enzyme, e.g., SHMT2, MTHFD1L, or MTHFD2, and optionally administering an antifolate or an agent that inhibits a mitochondrial 1-carbon (1-C) pathway enzyme, e.g., SHMT2 or MTHFD2. | 02-04-2016 |
Ronny Nilsson, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20120243538 | METHOD AND APPARATUS FOR PRE-CLASSIFYING PACKETS - The disclosed embodiments relate to a system that provides an intelligent port infrastructure for communication network devices. This is accomplished by incorporating a highly configurable pre-classifier module into the port infrastructure. This pre-classifier makes it possible to realign packet data to add a configurable number of bytes to the front of the packet, and also to select interesting data from incoming packets for further analysis. The selected data is sent into a configurable classification engine, which generates instructions that specify how to determine associated packet attributes. The packet attributes are then generated based on the instructions, and are forwarded along with the packet to downstream processing units. | 09-27-2012 |
20150215204 | METHOD AND APPARATUS FOR PRE-CLASSIFYING PACKETS - The disclosed embodiments relate to a system that provides an intelligent port infrastructure for communication network devices. This is accomplished by incorporating a highly configurable pre-classifier module into the port infrastructure. This pre-classifier makes it possible to realign packet data to add a configurable number of bytes to the front of the packet, and also to select interesting data from incoming packets for further analysis. The selected data is sent into a configurable classification engine, which generates instructions that specify how to determine associated packet attributes. The packet attributes are then generated based on the instructions, and are forwarded along with the packet to downstream processing units. | 07-30-2015 |